Pediatric Schizophrenia or Bipolar 1 Disorder
![](https://www.wakeclinical.com/wp-content/uploads/2023/04/PediatricCover.jpg)
A Study For Children With Schizophrenia Or Bipolar I Disorder
To qualify, you must:
- Ages 10-17
- Be diagnosed with Schizophrenia or Bipolar 1 Disorder
- Be an outpatient or be able to be treated on an outpatient basis
- Currently treated with olanzapine or has had an inadequate response to current antipsychotic
Qualified participants will receive:
- Study-related medication at no cost
- Study-related medical exams at no cost
- Compensation for time
![](https://www.wakeclinical.com/wp-content/uploads/2023/03/PediatricFeatured.jpg)
![](https://www.wakeclinical.com/wp-content/uploads/2023/02/white-square.png)
![](https://www.wakeclinical.com/wp-content/uploads/2023/09/5.jpg)
Why Participate?
Contribute to the advancement of medical knowledge and treatments, while receiving expert medical care under close supervision.
![](https://www.wakeclinical.com/wp-content/uploads/2023/09/2.jpg)
Experience
The M3 Wake Research Network has powered innovation with over 9,100 Successful Clinical Trials in patients from 6 months to 85 years.
![](https://www.wakeclinical.com/wp-content/uploads/2023/09/4.jpg)
Safety
Patient safety is paramount with strict protocols and ethical guidelines, minimizing risks and ensuring thorough monitoring throughout the trial.
![](https://www.wakeclinical.com/wp-content/uploads/2022/12/news-bg.jpg)
Pharmacology Research Institute - Encino
Main Office
+1-818-705-7450
Our Hours
Mon: 8AM – 5PM
Tues: 8AM – 5PM
Wed: 8AM – 7PM
Thurs: 8AM – 7PM
Fri: 8AM – noon
Location
5400 Balboa Blvd.
Suite 120
Encino, CA 91316